Holen Sie sich die Stockscreener-App
303.62
1.25%
-3.66
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LRCX?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$307.28
Offen:
$301.855
24-Stunden-Volumen:
3.03M
Relative Volume:
0.29
Marktkapitalisierung:
$379.63B
Einnahmen:
$21.68B
Nettoeinkommen (Verlust:
$6.71B
KGV:
57.31
EPS:
5.298
Netto-Cashflow:
$6.00B
1W Leistung:
+12.67%
1M Leistung:
-2.17%
6M Leistung:
+27.05%
1J Leistung:
+136.47%
1-Tages-Spanne:
$298.86
$305.98
1-Wochen-Bereich:
$272.64
$311.39
52-Wochen-Spanne:
$125.02
$438.50
Lam Research Corp Stock (LRCX) Company Profile
Firmenname
Lam Research Corp
Sektor
Telefon
(510) 659-0200
Adresse
4650 CUSHING BLVD, FREMONT, CA
Compare LRCX vs ASML, AMAT, KLAC, TER
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRCX
Lam Research Corp
|
303.39 | 384.51B | 21.68B | 6.71B | 6.00B | 5.298 |
ASML
Asml Holding Nv
|
1,731.61 | 670.10B | 41.20B | 12.41B | 11.15B | 32.12 |
AMAT
Applied Materials Inc
|
470.91 | 376.47B | 29.02B | 8.51B | 5.34B | 10.64 |
KLAC
Kla Corp
|
186.68 | 245.45B | 13.09B | 4.67B | 4.01B | 3.5373 |
TER
Teradyne Inc
|
385.94 | 60.84B | 3.79B | 854.06M | 553.18M | 5.4031 |
Lam Research Corp Stock (LRCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-05-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2026-05-05 | Eingeleitet | Seaport Research Partners | Buy |
| 2026-04-02 | Herabstufung | Erste Group | Buy → Hold |
| 2026-01-29 | Hochstufung | Summit Insights | Hold → Buy |
| 2026-01-29 | Bestätigt | TD Cowen | Buy |
| 2026-01-15 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-15 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-10-23 | Bestätigt | TD Cowen | Buy |
| 2025-09-30 | Eingeleitet | HSBC Securities | Hold |
| 2025-09-29 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2025-09-23 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-09-22 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2025-09-02 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2025-08-14 | Fortgesetzt | Erste Group | Buy |
| 2025-07-31 | Herabstufung | Summit Insights | Buy → Hold |
| 2025-07-31 | Bestätigt | TD Cowen | Buy |
| 2025-07-10 | Eingeleitet | Goldman | Buy |
| 2025-04-24 | Bestätigt | TD Cowen | Buy |
| 2025-03-20 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-20 | Hochstufung | Susquehanna | Neutral → Positive |
| 2025-01-30 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2025-01-30 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-17 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-01-15 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-12-17 | Eingeleitet | Cleveland Research | Neutral |
| 2024-08-01 | Bestätigt | TD Cowen | Buy |
| 2024-05-13 | Eingeleitet | Jefferies | Buy |
| 2024-04-25 | Bestätigt | TD Cowen | Buy |
| 2024-04-19 | Hochstufung | B. Riley Securities | Neutral → Buy |
| 2024-04-18 | Bestätigt | Needham | Buy |
| 2024-04-16 | Eingeleitet | Evercore ISI | Outperform |
| 2024-04-11 | Fortgesetzt | Deutsche Bank | Hold |
| 2024-01-25 | Bestätigt | TD Cowen | Outperform |
| 2024-01-23 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2023-12-12 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-12-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-11-22 | Eingeleitet | Redburn Atlantic | Buy |
| 2023-10-17 | Eingeleitet | Raymond James | Outperform |
| 2023-10-13 | Hochstufung | Needham | Hold → Buy |
| 2023-09-15 | Eingeleitet | Wolfe Research | Outperform |
| 2023-07-24 | Bestätigt | Mizuho | Buy |
| 2023-07-24 | Hochstufung | Stifel | Hold → Buy |
| 2023-04-20 | Bestätigt | Berenberg | Buy |
| 2023-04-20 | Bestätigt | Evercore ISI | Outperform |
| 2023-04-20 | Bestätigt | JP Morgan | Overweight |
| 2023-04-20 | Bestätigt | Jefferies | Buy |
| 2023-04-20 | Bestätigt | Mizuho | Buy |
| 2023-04-20 | Bestätigt | Stifel | Hold |
| 2023-04-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2023-03-13 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-01-18 | Fortgesetzt | Stifel | Hold |
| 2022-12-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-10-20 | Bestätigt | B. Riley Securities | Neutral |
| 2022-10-20 | Bestätigt | BofA Securities | Buy |
| 2022-10-20 | Bestätigt | DA Davidson | Neutral |
| 2022-10-20 | Bestätigt | Evercore ISI | Outperform |
| 2022-10-20 | Bestätigt | JP Morgan | Overweight |
| 2022-10-20 | Bestätigt | Jefferies | Buy |
| 2022-10-20 | Hochstufung | Summit Insights | Hold → Buy |
| 2022-10-20 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-07-25 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2022-06-15 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2022-01-27 | Bestätigt | Barclays | Overweight |
| 2022-01-27 | Bestätigt | Deutsche Bank | Hold |
| 2022-01-27 | Bestätigt | Evercore ISI | Outperform |
| 2022-01-27 | Bestätigt | Stifel | Buy |
| 2022-01-27 | Bestätigt | Susquehanna | Neutral |
| 2022-01-27 | Bestätigt | UBS | Buy |
| 2022-01-26 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-01-12 | Bestätigt | Barclays | Overweight |
| 2022-01-10 | Bestätigt | BofA Securities | Buy |
| 2022-01-05 | Fortgesetzt | Jefferies | Buy |
| 2021-12-15 | Bestätigt | Deutsche Bank | Hold |
| 2021-10-21 | Bestätigt | B. Riley Securities | Buy |
| 2021-10-21 | Herabstufung | Summit Insights | Buy → Hold |
| 2021-10-15 | Eingeleitet | Piper Sandler | Neutral |
| 2021-09-14 | Herabstufung | Susquehanna | Positive → Neutral |
| 2021-09-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2021-07-29 | Bestätigt | Mizuho | Buy |
| 2021-07-29 | Bestätigt | Stifel | Buy |
| 2021-07-29 | Bestätigt | UBS | Buy |
| 2021-07-29 | Bestätigt | Wells Fargo | Equal Weight |
| 2021-03-31 | Eingeleitet | Bernstein | Outperform |
| 2021-01-28 | Bestätigt | Cowen | Outperform |
| 2021-01-08 | Herabstufung | Needham | Buy → Hold |
| 2020-12-17 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2020-10-22 | Bestätigt | Goldman | Buy |
| 2020-10-22 | Bestätigt | KeyBanc Capital Markets | Overweight |
| 2020-10-22 | Bestätigt | Mizuho | Buy |
| 2020-10-22 | Bestätigt | Morgan Stanley | Overweight |
| 2020-10-22 | Bestätigt | RBC Capital Mkts | Outperform |
| 2020-10-22 | Bestätigt | Stifel | Buy |
| 2020-10-22 | Bestätigt | UBS | Buy |
| 2020-09-21 | Hochstufung | Stifel | Hold → Buy |
| 2020-07-30 | Bestätigt | Cowen | Outperform |
| 2020-07-21 | Hochstufung | B. Riley FBR | Neutral → Buy |
| 2020-06-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-06-16 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-26 | Eingeleitet | Barclays | Overweight |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-04-08 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2020-04-03 | Hochstufung | Nomura | Neutral → Buy |
| 2020-04-02 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-03-27 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2020-03-27 | Hochstufung | UBS | Sell → Buy |
Alle ansehen
Lam Research Corp Aktie (LRCX) Neueste Nachrichten
The Zacks Analyst Blog Highlights Applied Materials, Lam Research and KLA - The Globe and Mail
Envestnet Portfolio Solutions Inc. Has $46.95 Million Position in Lam Research Corporation $LRCX - MarketBeat
Lam Research stock falls 3.29 percent after the close - AD HOC NEWS
Lam Research Corp. stock outperforms competitors despite losses on the day - MarketWatch
Lam Research Corp Stock (LRCX) Moved Down by 3.29% on Sep 23: What Signal Does It Send? - TradingKey
Nvidia and AMD Get the Headlines. The Real AI Winners Might Be Applied Materials and Lam Research. - Barchart.com
Lam Research (NASDAQ:LRCX) Trading Up 2.9%What's Next? - MarketBeat
Lam Research Corporation $LRCX Shares Acquired by Andra AP fonden - MarketBeat
State Street Corp Grows Position in Lam Research Corporation $LRCX - MarketBeat
LRCX Eyes Mid-40s Operating Margin: Is the Long-Term Goal Achievable? - Zacks Investment Research
Lam Research Corp (LRCX) Stock Up 4.9% but GF Value Says Overval - GuruFocus
Lam Research Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Lam Research Corp Stock (LRCX) Moved Up by 3.58% on Sep 21: Drivers Behind the Movement - TradingKey
Lam Research Stock Rises as Analysts Lift AI Capex Outlook - timothysykes.com
Lam Research and MicroStrategy among market cap stock movers on Friday - Investing.com Canada
Is Lam Research Corp (LRCX) Overvalued After 7.0% Rally? GF Valu - GuruFocus
Lam Research advances 7%, reversing some recent losses (LRCX:NASDAQ) - Seeking Alpha
Lam Research Corp. stock outperforms competitors on strong trading day - MarketWatch
Chip equipment stocks surge as Lam Research lea... - Pluang
Lam Research Climbs 5% as Chip Equipment Names Outrun the Sector; Applied Materials Rises 4%, KLA Corp. Gains 3% - Yahoo Finance
Lam Research Corp Stock (LRCX) Opened Up by 4.12% on Sep 18: Facts Behind the Movement - TradingKey
What's Going On With Lam Research Stock Friday? - Benzinga
442,227 Shares in Lam Research Corporation $LRCX Acquired by Nykredit A S - MarketBeat
Lam Research stock heads into the open after a 0.1% Nasdaq gain - AD HOC NEWS
U.S.-based Lam Research to invest ₹10,000 cr to scale up its India footprint - thehindu.com
Lam Research Falls as Sector Risk-Off Trade Appears to Outweigh Recent Company Positives - moomoo.com
Lam Research (NASDAQ:LRCX): Affordable Growth With Elite Profitability - ChartMill
Applied Materials, Lam Research Pledge Billions for India Chip Industry - marketscreener.com
Market Chatter: Applied Materials, Lam Research Pledge Billions for India Chip Industry - Moomoo
The Zacks Analyst Blog Highlights Cisco, Lam, Thermo Fisher Scientific, Ampco-Pittsburgh and Catalyst - Yahoo Finance
Lam Research stock heads into the open after a 0.6% Nasdaq dip - AD HOC NEWS
Lam Research Corporation $LRCX Stock Position Lifted by Bank of America Corp DE - MarketBeat
Lam Research (NASDAQ:LRCX) Stock Price Down 8.3%Time to Sell? - MarketBeat
Lam Research Corp. stock underperforms Monday when compared to competitors - MarketWatch
Lam Research Corp Stock (LRCX) Moved Down by 6.91% on Sep 14: What Signal Does It Send? - TradingKey
Lam Research Corporation Share PriceLRCX, RNS News, Articles, Quotes, & Charts (NASDAQ:LRCX) - Proactive financial news
Lam Research Lifts 2026 WFE Outlook as AI Demand Strains Fab Capacity - Yahoo Finance
Lam Research Corporation $LRCX Shares Acquired by The Manufacturers Life Insurance Company - MarketBeat
Lam Research stock heads into the open after a 5.6% drop - ad-hoc-news.de
Lam Research stock heads into the open after a 5.7% drop - ad-hoc-news.de
Lam Research Corp (LRCX) Shares Fall 5.7% -- What GF Score of 85 Tells Investors - GuruFocus
Lam Research CEO Timothy Archer sells $9.58 million in company stock By Investing.com - Investing.com Australia
Here's How Much $100 Invested In Lam Research 20 Years Ago Would Be Worth Today - Benzinga
Lam Research CEO Timothy Archer sells $9.58 million in company stock - Investing.com Australia
Lam Research Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Lam Research director Bethany Mayer sells $3m in shares By Investing.com - Investing.com South Africa
Lam Research director Bethany Mayer sells $3m in shares - investing.com
Lam Research at Goldman Sachs conference: demand stays red hot By Investing.com - Investing.com UK
Lam Research Insider Sold Shares Worth $9,577,800, According to a Recent SEC Filing - Moomoo
Lam Research (NASDAQ: LRCX) CEO exercises options and sells 30,000 shares - Stock Titan
Lam Research (NASDAQ: LRCX) director sells shares with no preset trading plan disclosed - Stock Titan
Finanzdaten der Lam Research Corp-Aktie (LRCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lam Research Corp-Aktie (LRCX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| ARCHER TIMOTHY | President and CEO |
Sep 09 '26 |
Sale |
319.26 |
30,000 |
9,577,800 |
1,075,966 |
| Mayer Bethany | Director |
Sep 09 '26 |
Sale |
314.74 |
9,557 |
3,007,970 |
20,995 |
0.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):